We are live on ! Find out more
PAI

ProQuest Associates IV Portfolio holdings

AUM $53M
1-Year Est. Return 3.35%
This Fund
S&P 500
This Quarter Est. Return
-2.43%
1 Year Est. Return
+3.35%
3 Year Est. Return
+113.14%
5 Year Est. Return
10 Year Est. Return
AUM
$246M
AUM Growth
-$11.6M
Cap. Flow
$0
Cap. Flow %
0%
Top 10 Hldgs %
100%
Holding
4
New
Increased
Reduced
Closed

Top Buys

No buys this quarter

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EGRX
1
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
$185M 75.43%
4,780,188
AGRX
2
DELISTED
Agile Therapeutics
AGRX
$38.5M 15.67%
2,531
IMDZ
3
DELISTED
Immune Design Corp.
IMDZ
$16M 6.51%
1,962,720
ANTH
4
DELISTED
Anthera Pharmaceuticals, Inc.
ANTH
$5.87M 2.39%
237,500

Similar funds

ProQuest Associates IV's Q2 2016 Portfolio in Review

As of Q2 2016, ProQuest Associates IV held 4 positions worth $246M, down 4.5% from $257M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Trading was light in Q2 2016: portfolio turnover was 0%. ProQuest Associates IV opened no new positions and made no exits, leaving the 4-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • ProQuest Associates IV's ten largest holdings make up 100% of its $246M portfolio in Q2 2016.
  • ProQuest Associates IV opened 0 new positions and closed 0 in Q2 2016.
  • ProQuest Associates IV's portfolio value fell 4.5% quarter-over-quarter to $246M.

Based on ProQuest Associates IV's 13F filing for Q2 2016, filed 12 Aug 2016.